Odisha's First Vaccine Manufacturing Plant to Start Production by May – News18

Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said on Sunday. Chairman 5T and Nabin Odisha VK Pandian visited the facility.

The plant at the Biotech Park in Andharua will have the capacity to produce 2.4 crore doses of different vaccines per day. At full capacity, this facility will be the biggest vaccine-producing plant in the country, the Chief Minister’s Office (CMO) said in a statement.

Pandian visited all the sub-units and interacted with the management and employees. He instructed state government agencies to assist in the commissioning of the plant within the next 3 months.

It is expected to produce over 15 vaccines for various diseases, including cholera and malaria. The Rs 1,500-crore vaccine plant will create direct employment for 1,500 people, with most of them being local recruits, the CMO said.

The variety of vaccines produced in Bhubaneswar will be supplied to many parts of the world, it added.

Led by Dr. Krishna Ella of Bharat Biotech Park fame, the project is in complete sync with the motto of HCM and Odisha that ‘every life is precious’. With vaccines from here, millions of lives will be safeguarded around the world.

Pandian has assured all help from the government and also informed of the recently approved biotechnology policy, which has been approved by HCM Naveen Patnaik’s cabinet.

He expressed confidence that with this large anchor manufacturing plant, many other complementary biotechnology-related product companies will be attracted to the Odisha Biotech Park, bringing major investments and creating jobs in this specialty field.

(with inputs from PTI)